tiprankstipranks
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market

Altamira Therapeutics (CYTOF) Cash flow

Compare
598 Followers

Altamira Therapeutics Cash Flow

CYTOF's free cash flow for Q2 2023 was CHF-3.86M. For the 2023 fiscal year, CYTOF's free cash flow was decreased by CHF-685.03K and operating cash flow was CHF-3.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
CHF -11.51MCHF -8.68MCHF -13.67MCHF -4.84MCHF -8.39M
Investing Cash Flow
CHF 1.44MCHF -2.14MCHF -3.51MCHF -2.31MCHF -3.00M
Financing Cash Flow
CHF 10.62MCHF 9.83MCHF 6.61MCHF 16.96MCHF 7.38M
End Cash Position
CHF 617.41KCHF 15.39KCHF 984.19KCHF 11.26MCHF 1.38M
Free Cash Flow
CHF -11.51MCHF -10.83MCHF -17.00MCHF -7.16MCHF -11.41M
Currency in CHF

Altamira Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis